Follow the people · Insider
Daniel Barber
Daniel Barber files insider transactions with the SEC as a president and ceo of Aquestive Therapeutics (AQST). We hold 6 disclosed purchases and sales filed since 26 July 2018, 4 of them in the last 90 days.
- Files forAQST
- Disclosed buys and sells6 in all, 4 in the last 90 days
- Last disclosure18 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 24 July 2018 — 17 August 2026President and CEO · Aquestive Therapeutics (AQST)37 Form 4 lines · source: SEC Form 4
Everything they disclosed
37 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 25,000 shares of Aquestive TherapeuticsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 4,631 shares of Aquestive TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 20,369 shares of Aquestive TherapeuticsSEC Form 417 July 2026Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 25,000 shares of Aquestive TherapeuticsSEC Form 416 June 2026Common Stock · traded 15 June 2026 · filed 16 June 2026
- ▼ sold on the open market 8,257 shares of Aquestive TherapeuticsSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- had shares withheld for tax on 335,922 shares of Aquestive TherapeuticsSEC Form 47 May 2026Common Stock · traded 5 May 2026 · filed 7 May 2026
- was granted 293,100 shares of Aquestive Therapeutics (a derivative holding)SEC Form 413 April 2026Performance Stock Units · traded 7 March 2025 · filed 13 April 2026
- was granted 262,000 shares of Aquestive TherapeuticsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 180,677 shares of Aquestive TherapeuticsSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- was granted 523,000 shares of Aquestive Therapeutics (a derivative holding)SEC Form 411 March 2026Non-Qualified Stock Option (right to buy) · traded 9 March 2026 · filed 11 March 2026
- was granted 523,000 shares of Aquestive Therapeutics (a derivative holding)SEC Form 411 March 2026Non-Qualified Stock Option (right to buy) · traded 9 March 2026 · filed 11 March 2026
- was granted 262,000 shares of Aquestive TherapeuticsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 180,677 shares of Aquestive TherapeuticsSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- ▼ sold on the open market 91,343 shares of Aquestive TherapeuticsSEC Form 429 September 2025Common Stock · traded 26 September 2025 · filed 29 September 2025
- ▼ sold on the open market 400 shares of Aquestive TherapeuticsSEC Form 422 September 2025Common Stock · traded 19 September 2025 · filed 22 September 2025
- was granted 408,000 shares of Aquestive Therapeutics (a derivative holding)SEC Form 411 March 2025Non-Qualified Stock Option (right to buy) · traded 7 March 2025 · filed 11 March 2025
- was granted 272,000 shares of Aquestive TherapeuticsSEC Form 411 March 2025Common Stock · traded 7 March 2025 · filed 11 March 2025
- had shares withheld for tax on 29,307 shares of Aquestive TherapeuticsSEC Form 411 March 2025Common Stock · traded 7 March 2025 · filed 11 March 2025
- had shares withheld for tax on 53,998 shares of Aquestive TherapeuticsSEC Form 411 March 2025Common Stock · traded 9 March 2025 · filed 11 March 2025
- had shares withheld for tax on 56,824 shares of Aquestive TherapeuticsSEC Form 42 October 2024Common Stock · traded 9 March 2024 · filed 2 October 2024
- had shares withheld for tax on 37,938 shares of Aquestive TherapeuticsSEC Form 412 March 2024Common Stock · traded 9 March 2024 · filed 12 March 2024
- was granted 363,900 shares of Aquestive Therapeutics (a derivative holding)SEC Form 411 March 2024Non-Qualified Stock Option (right to buy) · traded 7 March 2024 · filed 11 March 2024
- was granted 242,600 shares of Aquestive TherapeuticsSEC Form 411 March 2024Common Stock · traded 7 March 2024 · filed 11 March 2024
- was granted 223,500 shares of Aquestive Therapeutics (a derivative holding)SEC Form 49 August 2023Performance Stock Units · traded 9 August 2023 · filed 9 August 2023
- was granted 223,500 shares of Aquestive Therapeutics (a derivative holding)SEC Form 45 May 2023Performance Stock Units · traded 5 May 2023 · filed 5 May 2023
- was granted 447,000 shares of Aquestive TherapeuticsSEC Form 49 March 2023Common Stock · traded 9 March 2023 · filed 9 March 2023
- was granted 100,000 shares of Aquestive Therapeutics (a derivative holding)SEC Form 48 August 2022Non-Qualified Stock Option (right to buy) · traded 5 August 2022 · filed 8 August 2022
- ▲ bought on the open market 91,743 shares of Aquestive Therapeutics (a derivative holding)SEC Form 410 June 2022Warrant (Right to Buy) · traded 8 June 2022 · filed 10 June 2022
- ▲ bought on the open market 91,743 shares of Aquestive TherapeuticsSEC Form 410 June 2022Common Stock · traded 8 June 2022 · filed 10 June 2022
- was granted 225,000 shares of Aquestive Therapeutics (a derivative holding)SEC Form 414 March 2022Non-Qualified Stock Option (right to buy) · traded 10 March 2022 · filed 14 March 2022
- was granted 100,000 shares of Aquestive Therapeutics (a derivative holding)SEC Form 415 March 2021Non-Qualified Stock Option (right to buy) · traded 11 March 2021 · filed 15 March 2021
- was granted 110,000 shares of Aquestive Therapeutics (a derivative holding)SEC Form 418 March 2020Non-Qualified Stock Option (right to buy) · traded 16 March 2020 · filed 18 March 2020
- ▲ bought on the open market 2,000 shares of Aquestive TherapeuticsSEC Form 427 August 2019Common Stock · traded 27 August 2019 · filed 27 August 2019
- was granted 50,000 shares of Aquestive Therapeutics (a derivative holding)SEC Form 410 May 2019Non-Qualified Stock Option (right to buy) · traded 9 May 2019 · filed 10 May 2019
- was granted 70,000 shares of Aquestive Therapeutics (a derivative holding)SEC Form 44 March 2019Non-Qualified Stock Option (right to buy) · traded 28 February 2019 · filed 4 March 2019
- ▲ bought on the open market 1,000 shares of Aquestive TherapeuticsSEC Form 410 December 2018Common Stock · traded 10 December 2018 · filed 10 December 2018
- was granted 96,507 shares of Aquestive Therapeutics (a derivative holding)SEC Form 426 July 2018Stock Option (Right to Purchase) · traded 24 July 2018 · filed 26 July 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.